EVIDENCES-X™ global Phase II(b) clinical trial of Saroglitazar Mg in MASH has been successfully completed. The trial achieved its primary endpoint of resolution of steatohepatitis…
EVIDENCES-X™ global Phase II(b) clinical trial of Saroglitazar Mg in MASH has been successfully completed. The trial achieved its primary endpoint of resolution of steatohepatitis…
New Delhi. 13 November 2020. Quick Reaction Surface to Air Missile (QRSAM) System has achieved a major milestone by a direct hit on to a…